S'abonner

An Analysis of the Association of Society of Chest Pain Centers Accreditation to American College of Cardiology/American Heart Association Non–ST-Segment Elevation Myocardial Infarction Guideline Adherence - 14/09/13

Doi : 10.1016/j.annemergmed.2009.01.025 
Abhinav Chandra, MD a, , Seth W. Glickman, MD, MBA a, Fang-Shu Ou, MS b, W. Frank Peacock, MD c, James K. McCord, MD d, Charles B. Cairns, MD e, Eric D. Peterson, MD, MPH b, E. Magnus Ohman, MD b, W. Brian Gibler, MD f, Matthew T. Roe, MD, MHS b
a Duke University Medical Center, Durham, NC 
b Duke Clinical Research Institute, Durham, NC 
c The Cleveland Clinic, Cleveland, OH 
d Henry Ford Heart and Vascular Institute, Detroit, MI 
e University of North Carolina, Chapel Hill, NC 
f University of Cincinnati, College of Medicine, Cincinnati, OH 

Address for correspondence: Abhinav Chandra, MD, DUMC Box 3096, Durham, NC 27710; 919-416-8201, fax 919-681-8521

Résumé

Study objective

Since 2003, the Society of Chest Pain Centers (SCPC) has provided hospital accreditation for acute coronary syndrome care processes. Our objective is to evaluate the association between SCPC accreditation and adherence to the American College of Cardiology/American Heart Association (ACC/AHA) evidence-based guidelines for non–ST-segment elevation myocardial infarction (NSTEMI). The secondary objective is to describe the clinical outcomes and the association with accreditation.

Methods

We conducted a secondary analysis of data from patients with NSTEMI enrolled in the Can Rapid Risk Stratification of Unstable Angina Patients Suppress Adverse Outcomes With Early Implementation of the ACC/AHA Guidelines (CRUSADE) quality improvement initiative in 2005. The analysis explored differences between SCPC-accredited and nonaccredited hospitals in evidence-based therapy given within the first 24 hours (including aspirin, β-blocker, glycoprotein IIb/IIIa inhibitors, heparin, and ECG within 10 minutes).

Results

Of 33,238 patients treated at 21 accredited hospitals and 323 nonaccredited hospitals, those at SCPC-accredited centers (n=3,059) were more likely to receive aspirin (98.1% versus 95.8%; odds ratio [OR] 1.73; 95% confidence interval [CI] 1.06 to 2.83) and β-blockers (93.4% versus 90.6%; OR 1.68; 95% CI 1.04 to 2.70) within 24 hours than patients at non-SCPC-accredited centers (n=30,179). No difference was observed in obtaining a timely ECG (40.4% versus 35.2%; OR 1.28; 95% CI 0.98 to 1.67), administering a glycoprotein IIb/IIIa inhibitor (OR 1.30; 95% CI 0.93 to 1.80), or administering heparin (OR 1.12; 95% CI 0.74 to 1.70). Also, there was no significant difference in risk-adjusted mortality for patients treated at SCPC hospitals versus nonaccredited hospitals (3.4% versus 3.5%; adjusted OR 1.17; 95% CI 0.88 to 1.55).

Conclusion

SCPC-accredited hospitals had higher NSTEMI ACC/AHA evidence-based guideline adherence in the first 24 hours of care on 2 of the 5 measures. No difference in outcomes was observed. Further studies are needed to better understand the association between SCPC accreditation and improved care for patients with acute coronary syndrome.

Le texte complet de cet article est disponible en PDF.

Plan


 Provide process.asp?qs_id=4410 on this article at the journal's Web site, www.annemergmed.com.
 Supervising editor: Keith A. Marill, MD
 Author contributions: AC was responsible for study conception and design and drafting of the article. F-SO was responsible for analysis and interpretation of data. AC, SWG, F-SO, WFP, JKM, CBC, EDP, EMO, WBG, and MTR revised article critically for important intellectual content. AC, SWG, F-SO, WFP, JKM, CBC, EDP, EMO, WBG, and MTR were responsible for final approval of the submitted article. AC takes responsibility for the paper as a whole.
 Funding and support: By Annals policy, all authors are required to disclose any and all commercial, financial, and other relationships in any way related to the subject of this article, that might create any potential conflict of interest. See the Manuscript Submission Agreement in this issue for examples of specific conflicts covered by this statement. CRUSADE is funded by the Schering-Plough Corporation. Bristol-Myers Squibb/Sanofi-Aventis Pharmaceuticals Partnership provides additional funding support. Millennium Pharmaceuticals, Inc., also funded this work. WFP and JKM are directly involved with the Society of Chest Pain Centers. No other conflict of interest exists as related to the topic of this manuscript.
 Publication date: Available online March 12, 2009.
 Reprints not available from the authors.


© 2008  American College of Emergency Physicians. Publié par Elsevier Masson SAS. Tous droits réservés.
Ajouter à ma bibliothèque Retirer de ma bibliothèque Imprimer
Export

    Export citations

  • Fichier

  • Contenu

Vol 54 - N° 1

P. 17-25 - juillet 2009 Retour au numéro
Article précédent Article précédent
  • The Limited Utility of Routine Cardiac Stress Testing in Emergency Department Chest Pain Patients Younger Than 40 Years
  • Luke K. Hermann, Scott D. Weingart, W. Lane Duvall, Milena J. Henzlova
| Article suivant Article suivant
  • Misdiagnosis of Long QT Syndrome as Epilepsy at First Presentation
  • Judith M. MacCormick, Hugh McAlister, Jackie Crawford, John K. French, Ian Crozier, Andrew N. Shelling, Carey-Anne Eddy, Mark I. Rees, Jonathan R. Skinner

Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.

Déjà abonné à cette revue ?

Mon compte


Plateformes Elsevier Masson

Déclaration CNIL

EM-CONSULTE.COM est déclaré à la CNIL, déclaration n° 1286925.

En application de la loi nº78-17 du 6 janvier 1978 relative à l'informatique, aux fichiers et aux libertés, vous disposez des droits d'opposition (art.26 de la loi), d'accès (art.34 à 38 de la loi), et de rectification (art.36 de la loi) des données vous concernant. Ainsi, vous pouvez exiger que soient rectifiées, complétées, clarifiées, mises à jour ou effacées les informations vous concernant qui sont inexactes, incomplètes, équivoques, périmées ou dont la collecte ou l'utilisation ou la conservation est interdite.
Les informations personnelles concernant les visiteurs de notre site, y compris leur identité, sont confidentielles.
Le responsable du site s'engage sur l'honneur à respecter les conditions légales de confidentialité applicables en France et à ne pas divulguer ces informations à des tiers.


Tout le contenu de ce site: Copyright © 2024 Elsevier, ses concédants de licence et ses contributeurs. Tout les droits sont réservés, y compris ceux relatifs à l'exploration de textes et de données, a la formation en IA et aux technologies similaires. Pour tout contenu en libre accès, les conditions de licence Creative Commons s'appliquent.